4.755
7.67%
-0.395
Dopo l'orario di chiusura:
4.72
-0.035
-0.74%
Aquestive Therapeutics Inc Azioni (AQST) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
8.73%
12.05
|
13.21 | 13.00 | 13.24 | 11.13 |
Cost Of Revenue |
6.20%
4.389
|
4.679 | 4.798 | 6.617 | 4.737 |
Gross Profit |
10.12%
7.664
|
8.527 | 8.204 | 6.624 | 6.397 |
Operating Expenses
|
33.63%
16.62
|
12.44 | 10.58 | 10.83 | 11.00 |
Interest Income/Expense |
22.48%
2.784
|
2.273 | 1.256 | 1.373 | 1.435 |
Benefits Costs and Expenses |
17.27%
24.88
|
21.22 | 15.18 | 18.75 | 3.066 |
Costs And Expenses |
22.74%
21.01
|
17.12 | 15.38 | 17.45 | 15.74 |
Depreciation and Amortization |
55.67%
0.207
|
0.467 | 0.264 | 0.289 | 0.325 |
Operating Income/Loss |
129.02%
-8.957
|
-3.911 | -2.377 | -4.209 | -4.605 |
Income/Loss From Continuing Operations Before Tax |
60.15%
-12.83
|
-8.01 | -2.175 | -5.508 | 8.068 |
Income Tax Expense/Benefit |
100.00%
-
|
0.101 | -0.14 | 0.284 | - |
Income/Loss From Continuing Operations After Tax |
58.16%
-12.83
|
-8.111 | -2.035 | -5.792 | 8.068 |
Net Income/Loss
|
58.16%
-12.83
|
-8.111 | -2.035 | -5.792 | 8.068 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3,575%
73.61
|
2.0031 | 64.68 | 57.35 | 55.63 |
Diluted Average Shares |
28,647%
73.61
|
-0.2579 | 64.68 | 57.35 | 73.79 |
Basic Earnings Per Share |
30.77%
-0.17
|
-0.13 | -0.03 | -0.10 | 0.15 |
Diluted Earnings Per Share |
30.77%
-0.17
|
-0.13 | -0.03 | -0.10 | 0.11 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):